No reduction of manual removal after misoprostol for retained placenta: A double-blind, randomized trial

Acta Obstetricia et Gynecologica Scandinavica

Volumn 92, Issue 4, 2013, Pages 398-403

  Van Stralen, Giel ^a   Veenhof, Marieke ^a   Holleboom, Cas ^c   Van Roosmalen, Jos ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

Manual removal; misoprostol; postpartum hemorrhage; prostaglandin E1; retained placenta

Indexed keywords

MISOPROSTOL;

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG HALF LIFE; DRUG SAFETY; DYSPEPSIA; FEMALE; GESTATIONAL AGE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; RETAINED PLACENTA; SHIVERING; VOMITING;

ADMINISTRATION, ORAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MISOPROSTOL; NETHERLANDS; OXYTOCICS; PLACENTA, RETAINED; POSTNATAL CARE; POSTPARTUM HEMORRHAGE; PREGNANCY; PUERPERAL DISORDERS; TREATMENT OUTCOME;

EID: 84875303930     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12065     Document Type: Article

References (20)

1. Nardin JM, Weeks A, Carroli G,. Umbilical vein injection for management of retained placenta (review). Cochrane Database Syst Rev. 2011; 5: CD001337.
2. Weeks AD, Mirembe FM,. Editorial. The retained placenta-new insights into an old problem. Eur J Obstet Gynecol Reprod Biol. 2002; 102: 109-10.
3. World Health Organization. The prevention and management of postpartum haemorrhage: report of a technical working group. 3-6 July 1989. Geneva: WHO, 1989.
4. Nordstrom L, Fogelstam K, Fridman G, Larsson A, Rydhstroem H,. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol. 1997; 104: 781-6.
5. Van Stralen G, van Roosmalen J,. Regarding Roger MS, Yen PM, Wong S. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol Scand. 2007; 86: 764.
6. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD,. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997; 90: 88-92.
7. Chong YS, Chua S, Shen L, Arulkumaran S,. Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery. Eur J Obstet Gynecol Reprod Biol. 2004; 113: 191-8.
8. Farmacotherapeutisch kompas. http://www.cvzkompassen.nl; July 2008.
9. Vogel D, Burkhardt T, Rentsch K, Schweer H, Watzer B, Zimmermann R, et al. Misoprostol versus methylergometrine: pharmacokinetics in human milk. Am J Obstet Gynecol. 2004; 191: 2168-73.
10. Abdel Aleem H,. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol 2003; 108: 25-8.
11. Deneux-Tharaux C, MacFarlane A, Winter C, Zang WH, Alexander S, Bouvier-Colle MH, the EUPHRATES group. Policies for manual removal of placenta at vaginal delivery: variations in timing within Europe. Br J Obstet Gynaecol. 2009; 116: 119-24.
12. Chedraui PA, Insuati DF,. Intravenous nitroglycerin in the management of retained placenta. Gynecol Obstet Invest. 2003; 56: 61-4.
13. Bullarbo M, Tjugum J, Ekerhovd E,. Sublingual nitroglycerin for management of retained placenta. Int J Gynecol Obstet. 2005; 91: 288-32.
14. Visaloyaputra S, Prechapanich J, Suwanvichai S, Yimyam S, Permpolprasert L, Suksopee P,. Intravenous nitroglycerin for controlled cord traction in the management of retained placenta. Int J Gynecol Obstet. 2011; 112: 103-6.
15. Van Beekhuizen HJ, De Groot ANJA, De Boo T, Burger D, Jansen N, Lotgering F,. Sulprostone reduces the need for manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Am J Obstet Gynecol. 2006; 194: 226-50.
16. Lim PS, Singh S, Lee A, Yassin MAJM,. Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta? Arch Gynecol Obstet. 2011; 248: 1073-9.
17. Harara R, Hanafi S, Zidan MSA, Alberry M,. Intraumbilical injection of three uterotonics in the management of retained placenta. J Obstet Gynecol Res. 2011; 9: 1203-7.
18. Rogers MS, Yuen PM, Wong S,. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol Scand. 2007; 86: 48-54.
19. Abdel-Aleem H, Abdel-Aleem MA, Shaaban OM,. Tocolysis for management of retained placenta. Cochrane Database Syst Rev. 2011; 1: CD007708.
20. Soltani H, Poulose TA, Hutchon DR,. Placental cord drainage after vaginal delivery as part of the management of the third stage of labour (review). Cochrane Database Syst Rev. 2011; 9: CD004665.